by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersPekCura Labs

All Warning Letters

PekCura Labs

Warning LetterOpen

Recipient Name Jonathan Snider, Owner, Recipient Title Jonathan Speck, Owner, 3210 Bayou Blvd Pensacola , FL 32503 United StatesIssued Mar 31, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations1

Issue DateMar 31, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: PekCura Labs
Location: Recipient Name Jonathan Snider, Owner, Recipient Title Jonathan Speck, Owner, 3210 Bayou Blvd Pensacola , FL 32503 United States
FEI Number: N/A
Country: United States
Issue Date: March 31, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

Unapproved New Drugs Sold Over the Internet

PekCura Labs FDA Warning Letter, March 31, 2026